Reference - Detail
| RRC ID | 6804 |
|---|---|
| Author | Nishiyama N, Nakagishi Y, Morimoto Y, Lai PS, Miyazaki K, Urano K, Horie S, Kumagai M, Fukushima S, Cheng Y, Jang WD, Kikuchi M, Kataoka K. |
| Title | Enhanced photodynamic cancer treatment by supramolecular nanocarriers charged with dendrimer phthalocyanine. |
| Journal | J Control Release |
| Abstract |
Photodynamic therapy (PDT) is a promising method for the localized treatment of solid tumors. In order to enhance the efficacy of PDT, we have recently developed a novel class of photosensitizer formulation, i.e., the dendrimer phthalocyanine (DPc)-encapsulated polymeric micelle (DPc/m). The DPc/m induced efficient and unprecedentedly rapid cell death accompanied by characteristic morphological changes such as blebbing of cell membranes, when the cells were photoirradiated using a low power halogen lamp or a high power diode laser. The fluorescent microscopic observation using organelle-specific dyes demonstrated that DPc/m might accumulate in the endo-/lysosomes; however, upon photoirradiation, DPc/m might be promptly released into the cytoplasm and photodamage the mitochondria, which may account for the enhanced photocytotoxicity of DPc/m. This study also demonstrated that DPc/m showed significantly higher in vivo PDT efficacy than clinically used Photofrin (polyhematoporphyrin esters, PHE) in mice bearing human lung adenocarcinoma A549 cells. Furthermore, the DPc/m-treated mice did not show skin phototoxiciy, which was apparently observed for the PHE-treated mice, under the tested conditions. These results strongly suggest the usefulness of DPc/m in clinical PDT. |
| Volume | 133(3) |
| Pages | 245-51 |
| Published | 2009-2-10 |
| DOI | 10.1016/j.jconrel.2008.10.010 |
| PII | S0168-3659(08)00634-2 |
| PMID | 19000725 |
| MeSH | Animals Cell Line, Tumor Cell Survival / drug effects Cell Survival / radiation effects Dendrimers / chemistry* Dihematoporphyrin Ether / administration & dosage Dihematoporphyrin Ether / chemistry Dihematoporphyrin Ether / therapeutic use Drug Delivery Systems / methods* Female Humans Indoles / administration & dosage* Indoles / chemistry Indoles / therapeutic use Isoindoles Lasers Liver / drug effects Liver / pathology Mice Mice, Inbred BALB C Micelles Nanoparticles Neoplasms / drug therapy* Neoplasms / metabolism Neoplasms / pathology Photochemotherapy / adverse effects Photochemotherapy / methods* Polyethylene Glycols / chemistry Polylysine / chemistry Radiation-Sensitizing Agents / administration & dosage Radiation-Sensitizing Agents / chemistry Radiation-Sensitizing Agents / therapeutic use Reactive Oxygen Species / metabolism Skin / drug effects Skin / pathology Xenograft Model Antitumor Assays |
| IF | 7.727 |
| Times Cited | 112 |
| WOS Category | PHARMACOLOGY & PHARMACY CHEMISTRY, MULTIDISCIPLINARY |
| Altmetric score |
オルトメトリクス指標項目
|
| The most frequently cited source | Patent(IFI CLAIMS) |
| Total number of mentions | 1 |
| Altmetric score changes over past 6months | 0.0 |
| Resource | |
| Human and Animal Cells | A549(RCB0098) |